This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Determining which travel rewards credit card is best can enhance your travel experiences. Explore your options for the best fit.
23,300 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A headline-grabbing $60 million deal with Harry and Meghan raised questions about value, expectations, and how to mea...
Warren Buffett recalibrates how he donates, moving away from a single grand plan toward annual gifts routed through h...
Could Starbucks be hiding dividend upside under a modest price tag? This guide breaks down how to judge whether starb...
Rivian is expanding beyond its trucks and SUVs into self-driving tech and ridesharing partnerships. This guide breaks...
A detailed look at the melinda french gates rule, a deliberate 48-hour pause before addressing work conflicts, and ho...
Immersed, a private VR work platform behind the work-from-VR trend, is closing its under-$1 retail round. Early metri...
A clear, investor-focused read on what The Trade Desk's Q1 2026 results mean for 2026. Discover growth drivers, margi...
A nationwide social security survey reveals a tax planning crisis among retirees, with 60% wishing they’d prepared mo...
XRP trades near key resistance as bets on the CLARITY Act shift. A May 14 committee vote could reshape price paths, w...
Former Goldman Sachs CEO Lloyd Blankfein warns that AI operates with speed but limited verifiability, a risk that cou...
A legendary TV send-off isn’t just about drama. It exposes the hidden costs of chaos—how budgets, insurance, and risk...